NCT00066326 2013-04-05Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous LeukemiaBarbara Ann Karmanos Cancer InstitutePhase 1 Completed